NCT02438423View on ClinicalTrials.gov

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

March 23, 2016

Study Completion Date

March 23, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

Inactivated influenza vaccine

Seasonal trivalent inactivated influenza vaccine FDA-approved for 2014-2015 influenza season

OTHER

Placebo

Trial Locations (1)

30030

The Hope Clinic, Decatur

All Listed Sponsors
collaborator

Emory University

OTHER

lead

Mark Prausnitz

OTHER

NCT02438423 - Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle | Biotech Hunter | Biotech Hunter